The aim of this study was to present the epidemiological, clinical and therapeutic aspects of adult urological cancers in the department of urology at Zinder National Hospital. Patients and Methods: This was a cross-sectional study of adult primary urologic cancers during the period of January 2019 to December 2023. Data were obtained from the record of patients admitted to urology, and the medical oncology department. The parameters studied were; frequency, age, sex, urogenital distribution, anatomopathological type, and therapeutic aspects. Data were recorded on Excel 2013 and analyzed with Epi-info version 7.2.5. Results: Epidemiology: About 289 cancers were diagnosed through 6017 consultations during the period, corresponding to 4.80% of urological pathologies: prostate cancer (n = 221; 76.47%), bladder cancer (n = 46; 15.92%), kidney cancer (n = 13; 04.5%), testis cancer (n = 09; 03.11%). Median age of patients was 50.42 years. Prostate cancer: was Adenocarcinoma in 100% (n = 221) with Gleason scores > 7 (77.83%) and prostatique specific antigen (PSA) > 20 ng/ml in 90.04%. Extension evaluation 134 cases (60.63%). Treatment was chirurgical castration in (62.44%) and resistance to castration appeared between 8 and 11 months. Hospital mortality for prostate cancer was 16.29%. Bladder cancer was found in 46 cases with Sex ratio 7/1. Cystoscopy was performed for all. Histology revealed squamous cell carcinoma (n = 41; 89.13%), and (n = 5; 10.87%) urothelial. Endoscopic resection performed (n = 14; 30.43%). Kidney cancers were 13 cases (10 men, 03 women). Nephrectomy was performed in (n = 8; 61.54%) cases and Histology revealed renal cell cancer in 76.92%. Testicular cancers were diag 09 cases. History of cryptorchidism was found in 4 cases, 4-year infertility in 3 cases. Orchidectomy was done in all cases. Chemotherapy in 3 cases. Conclusion: urological cancers are frequent, dominated by prostate cancer. The endemicity of bilharziasis has increased squamous cell carcinoma. The majority of patients have advanced form of the disease, which poses management problems.
References
[1]
Deo, S.V.S., Sharma, J. and Kumar, S. (2022) GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists. Annals of Surgical Oncology, 29, 6497-6500. https://doi.org/10.1245/s10434-022-12151-6
[2]
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-149. https://doi.org/10.3322/caac.21660
[3]
Garba, S.M., Zaki, H.M., Arfaoui, A., Hami, H., Soulaymani, A., Nouhou, H., et al. (2013) Épidémiologie des cancers au Niger, 1992 à 2009. Bulletin du Cancer, 100, 127-133. https://doi.org/10.1684/bdc.2013.1699
[4]
Ouedraogo, S., Traore, M.T., Kambire, J.L., Ouedraogo, S., Bere, B. and Kabore, A.F. (2019) Les cancers urologiques primitifs dans un contexte de ressources limitées : Épidémiologie et traitement. Bulletin du Cancer, 106, 868-874. https://doi.org/10.1016/j.bulcan.2019.06.003
[5]
Ouattara, A., Hodonou, R., Avakoudjo, J., Cisse, D., Zango, B., Gandaho, I., et al. (2012) Épidémiologie des cancers urologiques au Centre national hospitalier universitaire Hubert Koutoukou Maga Cotonou, Bénin. Analyse d’une série hospitalière de 158 cas. Progrès en Urologie, 22, 261-265. https://doi.org/10.1016/j.purol.2011.12.003
[6]
Igbokwe, M.C., Badmus, T.A., Salako, A.A., Komolafe, A.O., David, R.A., Omoyiola, O.Z., et al. (2020) Histomorphological Pattern of Urologic Malignancies in ILE-IFE, South-Western Nigeria. Annals of Ibadan Postgraduate Medicine, 18, 60-64.
[7]
Darré, T., Amégbor, K., Kpatcha, M., Tengue, K., Sonhaye, L., Doh, K., et al. (2014) Cancers urologiques au Togo : Profil histoépidémiologique à propos de 678 cas. Journal Africain du Cancer, 6, 27-31. https://doi.org/10.1007/s12558-013-0296-3
[8]
Adeloye, D., David, R.A., Aderemi, A.V., Iseolorunkanmi, A., Oyedokun, A., Iweala, E.E.J., et al. (2016) An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis. PLOS ONE, 11, e0153496. https://doi.org/10.1371/journal.pone.0153496
[9]
Halidou, M., Kodo, A., Diongolé, H., Zakou, A.R.H., Magagi, I. and Amadou, S. (2022) Prostate Cancer in Niger: Epidemiology, Clinical and Histological Features at the National Hospital of Zinder. Health Sciences and Disease, 23, 113-116. https://www.hsd-fmsb.org/
[10]
Sharma, R., Aashima Nanda, M., Fronterre, C., Sewagudde, P., Ssentongo, A.E., et al. (2022) Mapping Cancer in Africa: A Comprehensive and Comparable Characterization of 34 Cancer Types Using Estimates from GLOBOCAN 2020. Frontiers in Public Health, 10, Article 839835. https://doi.org/10.3389/fpubh.2022.839835
[11]
Ondo, C.Z., Ndiath, A., Sarr, A., Thiam, A., Sine, B., Sow, O., et al. (2021) Metastatic Prostate Cancer: Clinical Aspects and Treatment Limitations in a University Hospital Center in Senegal. African Journal of Urology, 27, Article No. 121. https://doi.org/10.1186/s12301-021-00223-0
[12]
Botcho, G., Kpatcha, T.M., Tengue, K., Leloua, E., Sikpa, K.H., Darre, T., et al. (2015) Advanced Prostate Cancer in Togo. Clinical and Management Aspects at the Teaching Hospital of Sylvanus Olympio. Journal de la Recherche Scientifique de l’Université de Lomé, 17, 663-672.
[13]
Cisse, D., Bangoura, M.F., Bah, M.B., Barry, M.I., Diallo, T.M. and Amougou, B. (2022) Management of Advanced Prostate Cancer at the Ignace Deen National Hospital of Conakry. Health Sciences and Disease, 23, 90-94. https://www.hsd-fmsb.org/
[14]
Cassell, A., Yunusa, B., Jalloh, M., Mbodji, M.M., Diallo, A., Ndoye, M., et al. (2019) A Review of Localized Prostate Cancer: An African Perspective. World Journal of Oncology, 10, 162-168. https://doi.org/10.14740/wjon1221
[15]
Diallo, I., Diamé, I.D., Diouf, C., Faye, S.T., Thiam, A., Yaya, A., et al. (2021) Urogenital Cancers in the Peripheral Region of Senegal: About 156 Cases. African Journal of Urology, 27, 9-16. https://doi.org/10.21608/afju.2021.9275
[16]
Konan, P.G., Gowe, E.E., Dekou, A.H., FoFana, A., Vodi, C.C., Kramo, N.F., et al. (2015) Prostate Cancer Metastasis in Cocody Teaching Hospital. Uro’Andro, 1, 172-176.
[17]
Ismaili, N., Afqir, S., Belbaraka, R., Elmajjaoui, S., Benjaafar, N., Tahri, A., et al. (2012) Cancers Urologiques : Congrès de l’ECCO/ESMO 2011. La Presse Médicale, 41, 1181-1187. https://doi.org/10.1016/j.lpm.2012.04.005
[18]
Ndiaye, M., Sow, O., Thiam, A., Sarr, A., Gaye, O., Sine, B., et al. (2020) Prostate Cancer in Aristide Le Dantec Hospital of Dakar: Epidemiological Aspects over the Last Five Years. Annales Africaines de Medecine, 14, e4004-e4009.
[19]
Adeloye, D., Harhay, M.O., Ayepola, O.O., Dos Santos, J.P., David, R.A., Ogunlana, O.O., et al. (2019) Estimate of the Incidence of Bladder Cancer in Africa: A Systematic Review and Bayesian Meta-Analysis. International Journal of Urology, 26, 102-112. https://doi.org/10.1111/iju.13824
[20]
Diao, B., Amath, T., Fall, B., Fall, P.A., Diémé, M.J., Steevy, N.N., et al. (2008) Les cancers de vessie au Sénégal : Particularités épidémiologiques, cliniques et histologiques. Progrès en Urologie, 18, 445-448. https://doi.org/10.1016/j.purol.2008.04.016
[21]
Yunusa, B., Abdullahi, M., Abbas Mashi, S., Ali Aji, S., Sani, A., Giade, S.A., et al. (2020) Bladder Cancer Burden and Challenges of Management in Kano, North Western Nigeria. Journal of Cancer Science and Clinical Therapeutics, 4, 424-433. https://www.fortunejournals.com/articles/bladder-cancer-burden-and-challenges-of-management-in-kano-north-western-nigeria.html
[22]
Tela, U.M., Adamu, A.I., Abubakar, B.M., Abubakar, A. and Dogo, H.M. (2021) Review of Urological Cancers in Damaturu, Nigeria. International Journal of Research in Medical Sciences, 9, 532-534. https://doi.org/10.18203/2320-6012.ijrms20210059
[23]
Salah, R., Harir, N., Zeggai, S., Sellam, F., Merabent, N.M., Moullessehoul, S., et al. (2015) Cancers urologiques en Algérie : Profil histoépidémiologique à propos de 348 cas. Journal Africain du Cancer, 7, 126-131. https://doi.org/10.1007/s12558-014-0342-9
[24]
Avakoudjo, J.D.G., Hounnasso, P.P., Gouissi, S.A.G., Agounkpe, M.M., Natchagande, G., Dandjlessa, O., et al. (2015) Bladder Tumors: Epidemiological and Diagnostic Aspects at the Cotonou National University Hospital (Republic of Benin). Journal de la Société de Biologie Clinique du Bénin, 22, 77-80.
[25]
Zakhama, W., Hammedi, F., Majdoub, A., M’nasser, A., Moussa, A., Njim, L., et al. (2016) Intérêt pronostique de l’infiltration du chorion dans les tumeurs vésicales pT1. African Journal of Urology, 22, 267-272. https://doi.org/10.1016/j.afju.2016.05.006
[26]
Tengue, K., Kpatcha, T.M., Botcho, G., Leloua, E., Amavi, A.K., Sikpa, K., et al. (2016) Profil épidémiologique, diagnostique, thérapeutique et évolutif du cancer de la prostate au Togo. African Journal of Urology, 22, 76-82. https://doi.org/10.1016/j.afju.2015.06.006
